Lipid nanoparticles for oral delivery of raloxifene: Optimization, stability, in vivo evaluation and uptake mechanism

被引:115
|
作者
Ravi, Punna Rao [1 ]
Aditya, N. [1 ]
Kathuria, Himanshu [1 ]
Malekar, Srinivas [1 ]
Vats, Rahul [1 ]
机构
[1] BITS Pilani Hyderabad Campus, Dept Pharm, Hyderabad, Andhra Pradesh, India
关键词
Raloxifene HCl; Solid lipid nanoparticle; Box-Bhenken design; Design of experiments; Everted gut sac; Lymphatic transport; Glyceryl behenate; BIODEGRADABLE POLYMERIC MICROSPHERES; INTESTINAL LYMPHATIC TRANSPORT; FLOW BLOCKING APPROACH; DRUG-DELIVERY; PHARMACOKINETICS; BIOAVAILABILITY; ABSORPTION; RELEASE; RATS; GLUCURONIDATION;
D O I
10.1016/j.ejpb.2013.12.015
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Raloxifene HCI (RLX) shows low oral bioavailability (<2%) in humans due to poor aqueous solubility and extensive (>90%) metabolism in gut. Lipid nanoparticles (SLN) with glyceryl tribehenate were designed to enhance drug's oral bioavailability. Box-Bhenken design was used to optimize manufacturing conditions. Optimized SLN had particle size of 167 +/- 3 nm and high encapsulation efficiency (>92%). Oral bioavailability of RLX from SLN was improved by 3.24 folds compared to free RLX in female Wistar rats. Both clathrin and caveolae mediated endocytosis pathways were involved in the uptake of SLN. Lymphatic transport inhibitor, cycloheximide significantly reduced oral bioavailability of SLN. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:114 / 124
页数:11
相关论文
共 50 条
  • [1] Solid lipid nanoparticles as vesicles for oral delivery of olmesartan medoxomil: formulation, optimization and in vivo evaluation
    Nooli, Mounika
    Chella, Naveen
    Kulhari, Hitesh
    Shastri, Nalini R.
    Sistla, Ramakrishna
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2017, 43 (04) : 611 - 617
  • [2] Chitosan nanoparticles for the oral delivery of tenofovir disoproxil fumarate: formulation optimization, characterization and ex vivo and in vivo evaluation for uptake mechanism in rats
    Shailender, Joseph
    Ravi, Punna Rao
    Sirukuri, Mrinalini Reddy
    Dalvi, Avantika
    Priya, Odapalli Keerthi
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2018, 44 (07) : 1109 - 1119
  • [3] Poly (ε-caprolactone) nanocapsules for oral delivery of raloxifene: process optimization by hybrid design approach, in vitro and in vivo evaluation
    Aditya, N.
    Ravi, Punna Rao
    Avula, Uday Sai Ranjan
    Vats, Rahul
    JOURNAL OF MICROENCAPSULATION, 2014, 31 (05) : 508 - 518
  • [4] Formulation and Optimization of Raloxifene-Loaded Solid Lipid Nanoparticles to Enhance Oral Bioavailability
    Tran, Tuan Hiep
    Ramasamy, Thiruganesh
    Cho, Hyuk Jun
    Kim, Yong Il
    Poudel, Bijay Kumar
    Choi, Han-Gon
    Yong, Chul Soon
    Kim, Jong Oh
    JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, 2014, 14 (07) : 4820 - 4831
  • [5] Evaluation of Oral Bioavailability and Anticancer Potential of Raloxifene Solid Lipid Nanoparticles
    Battani, Somashekhar
    Pawar, Harish
    Suresh, Sarasija
    JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, 2014, 14 (08) : 5638 - 5645
  • [6] Fabrication of solid lipid nanoparticles of lurasidone HCl for oral delivery: optimization, in vitro characterization, cell line studies and in vivo efficacy in schizophrenia
    Patel, Mitali H.
    Mundada, Veenu P.
    Sawant, Krutika K.
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2019, 45 (08) : 1242 - 1257
  • [7] Solid Lipid Nanoparticles for Oral Delivery of Decitabine: Formulation Optimization, Characterization, Stability and Ex-Vivo Gut Permeation Studies
    Neupane, Yub Raj
    Srivastava, Manish
    Gyenwalee, Suman
    Ahmad, Nafees
    Soni, Kriti
    Kohli, Kanchan
    SCIENCE OF ADVANCED MATERIALS, 2015, 7 (03) : 433 - 445
  • [8] Design, optimization and evaluation of poly-ε-caprolactone (PCL) based polymeric nanoparticles for oral delivery of lopinavir
    Ravi, Punna Rao
    Vats, Rahul
    Dalal, Vikas
    Gadekar, Nitin
    Aditya, N.
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2015, 41 (01) : 131 - 140
  • [9] Solid lipid nanoparticles as carriers for oral delivery of hydroxysafflor yellow A
    Zhao, Bingxiang
    Gu, Sufang
    Du, Yong
    Shen, Minjie
    Liu, Xiangrui
    Shen, Youqing
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2018, 535 (1-2) : 164 - 171
  • [10] Simvastatin Solid Lipid Nanoparticles for Oral Delivery: Formulation Development and In vivo Evaluation
    Padhye, S. G.
    Nagarsenker, Mangal S.
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 75 (05) : 591 - 598